MYH7 and hypertrophic cardiomyopathy: To clarify any differences in APs between mouse and man, we performed additional experiments and assessed the AP characteristics of hiPSC-CMs (see SI methods) from a hypertrophic cardiomyopathy patient carrying R403Q MYH7 mutation (MYH7 403/+, see family pedigree, Fig. S7C).